This is a multicenter, observational, retrospective study. The primary aim of this trial
is to describe patients and disease characteristics, as well as treatment pattern of
locally advanced and recurrent/metastatic cervical cancer (R/M and LACC) in Italy,
through a retrospective data capture, from January 2018 to December 2021.

Eligible cervical cancer patients will be identified by reviewing medical records and
physician notes (paper or electronic).

Disease will be defined as follow:

- Locally advanced cervical cancer: a large tumour within the cervix (more than 4cm)
or it has grown into the tissues around the cervix, but the cancer has not spread to
other organs; usually includes stage 2B, 3 and 4A (FIGO staging)

- Recurrent cervical cancer: local tumour regrowth or development of distant
metastasis discovered 6 months or more after complete regression of the treatment
(26)

- Metastatic cervical cancer: cancer spreads beyond the pelvis to other parts of the
body; usually defined as stage 4B (FIGO staging) Moreover, the patients'
characteristics will be stratified as low risk and high risk for locally advanced
cervical cancer and differences between their treatment partners will be reported.